Literature DB >> 26458937

Avalanche for shape and feature-based virtual screening with 3D alignment.

David J Diller1,2, Nancy D Connell3, William J Welsh4.   

Abstract

This report introduces a new ligand-based virtual screening tool called Avalanche that incorporates both shape- and feature-based comparison with three-dimensional (3D) alignment between the query molecule and test compounds residing in a chemical database. Avalanche proceeds in two steps. The first step is an extremely rapid shape/feature based comparison which is used to narrow the focus from potentially millions or billions of candidate molecules and conformations to a more manageable number that are then passed to the second step. The second step is a detailed yet still rapid 3D alignment of the remaining candidate conformations to the query conformation. Using the 3D alignment, these remaining candidate conformations are scored, re-ranked and presented to the user as the top hits for further visualization and evaluation. To provide further insight into the method, the results from two prospective virtual screens are presented which show the ability of Avalanche to identify hits from chemical databases that would likely be missed by common substructure-based or fingerprint-based search methods. The Avalanche method is extended to enable patent landscaping, i.e., structural refinements to improve the patentability of hits for deployment in drug discovery campaigns.

Keywords:  Antibacterial drug discovery; Shape matching; Three dimensional alignment; Virtual screening

Mesh:

Substances:

Year:  2015        PMID: 26458937     DOI: 10.1007/s10822-015-9875-y

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  29 in total

1.  Comparative evaluation of 3D virtual ligand screening methods: impact of the molecular alignment on enrichment.

Authors:  David Giganti; Hélène Guillemain; Jean-Louis Spadoni; Michael Nilges; Jean-François Zagury; Matthieu Montes
Journal:  J Chem Inf Model       Date:  2010-06-28       Impact factor: 4.956

Review 2.  Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Authors:  David J Payne; Michael N Gwynn; David J Holmes; David L Pompliano
Journal:  Nat Rev Drug Discov       Date:  2006-12-08       Impact factor: 84.694

3.  Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors.

Authors:  Sandhya Kortagere; William J Welsh
Journal:  J Comput Aided Mol Des       Date:  2006-10-13       Impact factor: 3.686

Review 4.  Molecule-pharmacophore superpositioning and pattern matching in computational drug design.

Authors:  Gerhard Wolber; Thomas Seidel; Fabian Bendix; Thierry Langer
Journal:  Drug Discov Today       Date:  2007-11-05       Impact factor: 7.851

5.  New predictive models for blood-brain barrier permeability of drug-like molecules.

Authors:  Sandhya Kortagere; Dmitriy Chekmarev; William J Welsh; Sean Ekins
Journal:  Pharm Res       Date:  2008-04-16       Impact factor: 4.200

6.  Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.

Authors:  Sandhya Kortagere; Ernest Mui; Rima McLeod; William J Welsh
Journal:  J Comput Aided Mol Des       Date:  2011-02-26       Impact factor: 3.686

7.  Predicting inhibitors of acetylcholinesterase by regression and classification machine learning approaches with combinations of molecular descriptors.

Authors:  Dmitriy Chekmarev; Vladyslav Kholodovych; Sandhya Kortagere; William J Welsh; Sean Ekins
Journal:  Pharm Res       Date:  2009-07-15       Impact factor: 4.200

8.  Application of screening methods, shape signatures and engineered biosensors in early drug discovery process.

Authors:  Izabela Hartman; Alison R Gillies; Sonia Arora; Christina Andaya; Nitya Royapet; William J Welsh; David W Wood; Randy J Zauhar
Journal:  Pharm Res       Date:  2009-07-22       Impact factor: 4.200

9.  Hybrid scoring and classification approaches to predict human pregnane X receptor activators.

Authors:  Sandhya Kortagere; Dmitriy Chekmarev; William J Welsh; Sean Ekins
Journal:  Pharm Res       Date:  2008-12-30       Impact factor: 4.200

10.  Fragment-based Shape Signatures: a new tool for virtual screening and drug discovery.

Authors:  Randy J Zauhar; Eleonora Gianti; William J Welsh
Journal:  J Comput Aided Mol Des       Date:  2013-12-24       Impact factor: 3.686

View more
  4 in total

1.  MolAlign: an algorithm for aligning multiple small molecules.

Authors:  Shek Ling Chan
Journal:  J Comput Aided Mol Des       Date:  2017-06-01       Impact factor: 3.686

2.  Virtual Screening and Experimental Testing of B1 Metallo-β-lactamase Inhibitors.

Authors:  Joon S Kang; Antonia L Zhang; Mohammad Faheem; Charles J Zhang; Ni Ai; John D Buynak; William J Welsh; Peter Oelschlaeger
Journal:  J Chem Inf Model       Date:  2018-08-29       Impact factor: 4.956

3.  Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.

Authors:  Stanley G Kimani; Sushil Kumar; Nitu Bansal; Kamalendra Singh; Vladyslav Kholodovych; Thomas Comollo; Youyi Peng; Sergei V Kotenko; Stefan G Sarafianos; Joseph R Bertino; William J Welsh; Raymond B Birge
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

4.  QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs.

Authors:  Yangxi Yu; Hiep Dong; Youyi Peng; William J Welsh
Journal:  Molecules       Date:  2021-08-30       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.